Skip to content

ADX NEUROSCIENCES

Absorbed by Fujirebio Europe on 01-04-2026 Public limited companyKBO/BCE: BE 0839.400.980

Lifetime

14 annual accounts with figures on one time axis
peak of €3.0m in 2023
€1.6m▲ 77.4%
lowest -€937,912 in 2013
-€380,057▲ €145,061
peak of €5.1m in 2024
€4.2m▼ 8.3%
€661,069▼ 47.8%
peak of 18.8 FTE in 2026
18.8 FTE▲ 13.9%
Board4 names since 2022
3 directors and 2 others
Owners5 names in the annual accounts
consolidates
Documentsfilings and deeds
31-07-202692 days before the deadline
2026abbreviated format
Gross margin from €911,748 to €1.6mLoss of €380,057Staff from 16.5 FTE to 18.8 FTEMerger: absorbed by FUJIREBIO EUROPE 08-05Merger proposal: to be absorbed by Fujirebio Europe 19-02Debts from €1.3m to €661,069

Key points

from the 2026 annual accounts, the last ones filed

Losses

-€905,176 in two years
-525,1192025-380,0572026

The 2025 and 2026 financial years closed with a loss. 2025 was the heaviest.

Investments

€5,071 0.0 times depreciation
20212023202420252026

Green is investment, beige is depreciation.

Staff

19 employees on 31-03-2026
522021132023332024742025322026

In 2026, 3 employees joined and 2 left.

Liquidity

9.14 was 4.71 in 2025

Short-term debts fell from €1.1m to €485,059.

Filings

14 annual accounts since 2012
deadline201520202025

The 2023 accounts came 8 days late. The other nine of the last ten were filed on time.

Public support

€617,498 awarded in 2024

ADX NEUROSCIENCES was awarded €617,498 in EU support in 2024, under Horizon Europe.

Board and ownership

Director
Director, since 31-03-2026
Director, since 31-03-2026
Auditor,
Board & ownership

Recent changes

Merger: absorbed by FUJIREBIO EUROPE Dissolution of the company · Dissolved without liquidation on 01-04-2026 · , , and resign · Gazette deed
Listed in the Peppol Directory
Merger proposal: to be absorbed by Fujirebio Europe acts as permanent representative · Board meeting of 12-01-2026 · Gazette deed
reappointed as managing director acts as permanent representative · General meeting of 31-07-2024 · Gazette deed
All 43 events

Official details

Source: KBO
Status
Absorbed by Fujirebio Europemerger by absorption, April 2026
Legal form
Public limited company
Activity
“Het uitvoeren van alle vormen van onderzoek en ontwikkeling op biologische verbindingen, alsmede de…” (deed in Dutch)From the articles, 8 activitiesNo NACE code in the KBO
Joint committee
207White-collar workers in the chemical industry · annual accounts 31-03-2026
Financial year end
31 March
Peppol
Listed since 27-03-2026
Company details

Annual accounts to 31-03-2026

≈ €2.8mestimated
€4.9m▼ 16.8%
Employeeson 31-03-2026
19▲ 5.6%
Filing
Filed on 31-07-2026
Financials

Insights on ADX NEUROSCIENCES

Absorbed by Fujirebio Europe in April 2026. The last annual accounts are for financial year 2026. The company was dissolved without liquidation on 01-04-2026.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ADX NEUROSCIENCES

What is the company number of ADX NEUROSCIENCES?
The company number of ADX NEUROSCIENCES is 0839.400.980. The VAT number is the same number with BE in front: BE 0839.400.980.
What is the legal form of ADX NEUROSCIENCES?
ADX NEUROSCIENCES is a public limited company (NV).
Is ADX NEUROSCIENCES still active?
No. Absorbed in a merger on 01-04-2026. The company has been out of the KBO register since 30-04-2026.Company details
How many employees did ADX NEUROSCIENCES have?
ADX NEUROSCIENCES had an average of 18.8 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
Which joint committee does ADX NEUROSCIENCES fall under?
In its 31-03-2026 annual accounts, ADX NEUROSCIENCES states joint committee 207 (White-collar workers in the chemical industry).
What is the turnover of ADX NEUROSCIENCES?
The turnover in financial year 2026 is about €2.8m. This figure is estimated from the gross margin of €1.6m and 1,576 comparable companies of the same size. It probably lies between €1.9m and €4.6m. It is a rough estimate.
Is ADX NEUROSCIENCES profitable?
In financial year 2026, ADX NEUROSCIENCES made a loss of €380,057.
Where can I find the annual accounts of ADX NEUROSCIENCES?
ADX NEUROSCIENCES filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2026.

Next steps

Keep this company with today's facts in a case file.